These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

556 related articles for article (PubMed ID: 28364861)

  • 1. Laser therapy for the restoration of vaginal function.
    Gambacciani M; Palacios S
    Maturitas; 2017 May; 99():10-15. PubMed ID: 28364861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaginal erbium laser: the second-generation thermotherapy for the genitourinary syndrome of menopause.
    Gambacciani M; Levancini M; Cervigni M
    Climacteric; 2015 Oct; 18(5):757-63. PubMed ID: 26029987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term effect of vaginal erbium laser on the genitourinary syndrome of menopause.
    Gambacciani M; Levancini M
    Minerva Ginecol; 2015 Apr; 67(2):97-102. PubMed ID: 25763800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale and design for fractional microablative CO
    Flint R; Cardozo L; Grigoriadis T; Rantell A; Pitsouni E; Athanasiou S
    Climacteric; 2019 Jun; 22(3):307-311. PubMed ID: 30676818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of non-invasive vulvovaginal rejuvenation.
    Photiou L; Lin MJ; Dubin DP; Lenskaya V; Khorasani H
    J Eur Acad Dermatol Venereol; 2020 Apr; 34(4):716-726. PubMed ID: 31714632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationale and design for the Vaginal Erbium Laser Academy Study (VELAS): an international multicenter observational study on genitourinary syndrome of menopause and stress urinary incontinence.
    Gambacciani M; Torelli MG; Martella L; Bracco GL; Casagrande AG; Albertin E; Tabanelli S; Viglietta M; D'Ambrogio G; Garone G; Cervigni M
    Climacteric; 2015; 18 Suppl 1():43-8. PubMed ID: 26366800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effects of vaginal erbium laser in the treatment of genitourinary syndrome of menopause.
    Gambacciani M; Levancini M; Russo E; Vacca L; Simoncini T; Cervigni M
    Climacteric; 2018 Apr; 21(2):148-152. PubMed ID: 29436235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaginal laser therapy for GSM/VVA: where we stand now - a review by the EUGA Working Group on Laser.
    Salvatore S; Ruffolo AF; Phillips C; Athanasiou S; Cardozo L; Serati M;
    Climacteric; 2023 Aug; 26(4):336-352. PubMed ID: 37395104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraurethral Erbium:YAG laser for the management of urinary symptoms of genitourinary syndrome of menopause: A pilot study.
    Gaspar A; Maestri S; Silva J; Brandi H; Luque D; Koron N; Vižintin Z
    Lasers Surg Med; 2018 Oct; 50(8):802-807. PubMed ID: 29667744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genitourinary syndrome of menopause (GSM) and laser VEL: a review.
    Elia D; Gambacciani M; Berreni N; Bohbot JM; Druckmann R; Geoffrion H; Haab F; Heiss N; Rygaloff N; Russo E
    Horm Mol Biol Clin Investig; 2019 Dec; 41(1):. PubMed ID: 31855563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genitourinary syndrome of menopause and the use of laser therapy.
    Hutchinson-Colas J; Segal S
    Maturitas; 2015 Dec; 82(4):342-5. PubMed ID: 26323234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cost-effectiveness analysis of vaginal carbon dioxide laser therapy compared with standard medical therapies for genitourinary syndrome of menopause-associated dyspareunia.
    Wallace SL; St Martin B; Lee K; Sokol ER
    Am J Obstet Gynecol; 2020 Dec; 223(6):890.e1-890.e12. PubMed ID: 32562659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Two wavelengths endovaginal laser system": Clinical evaluation of a new device for mild SUI and vaginal atrophy treatment.
    Mezzana P
    Dermatol Ther; 2020 Nov; 33(6):e14445. PubMed ID: 33098352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IUGA committee opinion: laser-based vaginal devices for treatment of stress urinary incontinence, genitourinary syndrome of menopause, and vaginal laxity.
    Shobeiri SA; Kerkhof MH; Minassian VA; Bazi T;
    Int Urogynecol J; 2019 Mar; 30(3):371-376. PubMed ID: 30523374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microablative fractional CO
    Pitsouni E; Grigoriadis T; Tsiveleka A; Zacharakis D; Salvatore S; Athanasiou S
    Maturitas; 2016 Dec; 94():131-136. PubMed ID: 27823733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laser Therapy for Genitourinary Syndrome of Menopause.
    Rabley A; O'Shea T; Terry R; Byun S; Louis Moy M
    Curr Urol Rep; 2018 Aug; 19(10):83. PubMed ID: 30117032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CO2-Laser therapy and Genitourinary Syndrome of Menopause: A Systematic Review and Meta-Analysis.
    Filippini M; Porcari I; Ruffolo AF; Casiraghi A; Farinelli M; Uccella S; Franchi M; Candiani M; Salvatore S
    J Sex Med; 2022 Mar; 19(3):452-470. PubMed ID: 35101378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and long-term efficacy of fractional CO
    Behnia-Willison F; Sarraf S; Miller J; Mohamadi B; Care AS; Lam A; Willison N; Behnia L; Salvatore S
    Eur J Obstet Gynecol Reprod Biol; 2017 Jun; 213():39-44. PubMed ID: 28419911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ablative dual-phase Erbium:YAG laser treatment of atrophy-related vaginal symptoms in post-menopausal breast cancer survivors omitting hormonal treatment.
    Mothes AR; Runnebaum M; Runnebaum IB
    J Cancer Res Clin Oncol; 2018 May; 144(5):955-960. PubMed ID: 29487993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-invasive treatment of vulvovaginal atrophy in menopause with CO2 laser.
    D'Oria O; Giannini A; Prata G; Scudo M; Logoteta A; Mondo A; Perniola G; Palaia I; Cascialli G; Monti M; Muzii L; Benedetti Panici P; DI Donato V
    Minerva Obstet Gynecol; 2021 Apr; 73(2):127-134. PubMed ID: 32720802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.